Spots Global Cancer Trial Database for Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of Specific Biomarkers in Primary Invasive Breast Cancer
Official Title: A Prospective, Exploratory Observational Study Evaluating Specific Biomarkers in Primary Invasive Breast Cancer and Their Modulation by Standard Neoadjuvant Therapy
Study ID: NCT01476111
Conditions
Interventions
Study Description
Brief Summary: This study will examine specific biomarkers in primary invasive breast cancer and explore their correlation with patient outcome following standard neoadjuvant treatment.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Newark, Delaware, United States
GSK Investigational Site, Plantation, Florida, United States
GSK Investigational Site, Charleston, South Carolina, United States
GSK Investigational Site, Amarillo, Texas, United States
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Namur, , Belgium
GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, Germany
GSK Investigational Site, Erlangen, Bayern, Germany
GSK Investigational Site, Frankfurt, Hessen, Germany
GSK Investigational Site, Rostock, Mecklenburg-Vorpommern, Germany
GSK Investigational Site, Dortmund, Nordrhein-Westfalen, Germany
GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Homburg, Saarland, Germany
GSK Investigational Site, Chemnitz, Sachsen, Germany
GSK Investigational Site, Kiel, Schleswig-Holstein, Germany
GSK Investigational Site, Napoli, Campania, Italy
GSK Investigational Site, Aviano (PN), Friuli-Venezia-Giulia, Italy
GSK Investigational Site, Roma, Lazio, Italy
GSK Investigational Site, Milano, Lombardia, Italy
GSK Investigational Site, Pavia, Lombardia, Italy
GSK Investigational Site, Torino, Piemonte, Italy
GSK Investigational Site, Ryazan, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, Bournemouth, , United Kingdom
GSK Investigational Site, Derby, , United Kingdom
GSK Investigational Site, Edinburgh, , United Kingdom
GSK Investigational Site, Nottingham, , United Kingdom
GSK Investigational Site, Poole, , United Kingdom
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
